Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Xuelei Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9148-5001; OpenAlex author ID A5022157306. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Dual blockade of PD-1 and NKG2A prevents NK cell senescence and reprograms the immunosuppressive microenvironment in pancreatic cancer. Last author DOI 10.1016/j.celrep.2026.117583↗
  2. Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasis. Co-author DOI 10.1038/s41392-025-02265-0↗
  3. Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing. Co-author DOI 10.1016/j.xpro.2023.102539↗
  4. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis. Last author DOI 10.1097/md.0000000000018581↗
  5. A new proposal of utilizing intraoperative electron radiation therapy on the surface of liver to prevent postoperative liver metastasis of pancreatic cancer. Last author DOI 10.1016/j.mehy.2019.02.050↗
  6. Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis. Last author DOI 10.1016/j.gene.2018.09.029↗
  7. Prognostic role of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. Co-author DOI 10.7314/apjcp.2014.15.15.6015↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaowei Liu · 2 shared papers, 2023–2025 · strength 0.39
  2. Hubing Shi · 2 shared papers, 2023–2025 · strength 0.39
  3. Yu Zhang · 1 shared paper, 2026 · strength 0.21
  4. Yuting Jiang · 1 shared paper, 2026 · strength 0.21
  5. Haitao Zhang · 1 shared paper, 2026 · strength 0.21
  6. Yiting Dong · 1 shared paper, 2019 · strength 0.14
  7. Hao Zhang · 1 shared paper, 2020 · strength 0.13
  8. Jianqi Hao · 1 shared paper, 2020 · strength 0.13
  9. Yuzhou Zhu · 1 shared paper, 2020 · strength 0.13
  10. Linyan Chen · 1 shared paper, 2018 · strength 0.10
  11. Ping Li · 1 shared paper, 2014 · strength 0.05
  12. Yanyan Li · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.